Shin Nippon Biomedical Laboratories Future Growth
Future criteria checks 3/6
Shin Nippon Biomedical Laboratories is forecast to grow earnings and revenue by 15.2% and 11.1% per annum respectively while EPS is expected to grow by 15.2% per annum.
Key information
15.2%
Earnings growth rate
15.2%
EPS growth rate
Life Sciences earnings growth | 18.4% |
Revenue growth rate | 11.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 Aug 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 37,750 | 8,450 | 6,923 | N/A | 2 |
3/31/2025 | 34,000 | 6,939 | 5,491 | N/A | 2 |
3/31/2024 | 30,450 | 5,073 | 1,136 | N/A | 2 |
6/30/2023 | 26,848 | 5,489 | N/A | N/A | N/A |
3/31/2023 | 25,090 | 6,060 | -950 | 4,004 | N/A |
12/31/2022 | 21,173 | 6,231 | N/A | N/A | N/A |
9/30/2022 | 20,135 | 8,043 | 4,382 | 7,170 | N/A |
6/30/2022 | 18,753 | 7,245 | N/A | N/A | N/A |
3/31/2022 | 17,748 | 7,127 | 4,339 | 5,952 | N/A |
12/31/2021 | 17,636 | 7,432 | N/A | N/A | N/A |
9/30/2021 | 16,068 | 6,025 | 4,075 | 5,301 | N/A |
6/30/2021 | 14,978 | 4,844 | N/A | N/A | N/A |
3/31/2021 | 15,110 | 3,661 | 3,629 | 4,746 | N/A |
12/31/2020 | 14,910 | 2,421 | N/A | N/A | N/A |
9/30/2020 | 15,175 | 2,812 | 1,389 | 2,706 | N/A |
6/30/2020 | 15,004 | 3,234 | N/A | N/A | N/A |
3/31/2020 | 14,561 | 2,550 | 1,788 | 3,018 | N/A |
12/31/2019 | 13,497 | 1,990 | N/A | N/A | N/A |
9/30/2019 | 13,167 | 1,915 | 1,784 | 2,988 | N/A |
6/30/2019 | 14,676 | 1,524 | N/A | N/A | N/A |
3/31/2019 | 15,658 | 1,950 | 1,794 | 2,892 | N/A |
12/31/2018 | 17,337 | -49 | N/A | N/A | N/A |
9/30/2018 | 17,928 | -993 | 1,631 | 2,943 | N/A |
6/30/2018 | 16,937 | -2,566 | N/A | N/A | N/A |
3/31/2018 | 16,600 | -3,555 | 326 | 1,344 | N/A |
12/31/2017 | 17,186 | -1,072 | N/A | N/A | N/A |
9/30/2017 | 17,714 | 327 | -171 | 280 | N/A |
6/30/2017 | 17,230 | 260 | N/A | N/A | N/A |
3/31/2017 | 17,244 | -915 | N/A | -849 | N/A |
12/31/2016 | 15,880 | -1,821 | N/A | N/A | N/A |
9/30/2016 | 15,269 | -1,273 | N/A | -3,109 | N/A |
6/30/2016 | 14,922 | -1,475 | N/A | N/A | N/A |
3/31/2016 | 14,750 | 2,646 | N/A | -3,339 | N/A |
12/31/2015 | 15,637 | 2,060 | N/A | N/A | N/A |
9/30/2015 | 16,344 | 401 | N/A | -2,379 | N/A |
6/30/2015 | 17,164 | 1,546 | N/A | N/A | N/A |
3/31/2015 | 17,835 | -1,385 | N/A | -2,156 | N/A |
12/31/2014 | 18,058 | -417 | N/A | N/A | N/A |
9/30/2014 | 17,161 | -599 | N/A | -1,377 | N/A |
6/30/2014 | 17,132 | -1,074 | N/A | N/A | N/A |
3/31/2014 | 16,926 | -754 | N/A | -1,620 | N/A |
12/31/2013 | 16,993 | -1,443 | N/A | N/A | N/A |
9/30/2013 | 17,513 | -1,185 | N/A | -1,495 | N/A |
6/30/2013 | 16,837 | -1,044 | N/A | N/A | N/A |
3/31/2013 | 17,154 | -1,152 | N/A | 90 | N/A |
12/31/2012 | 15,928 | -2,456 | N/A | N/A | N/A |
9/30/2012 | 16,010 | -2,986 | N/A | -381 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SBLO.F's forecast earnings growth (15.2% per year) is above the savings rate (2.2%).
Earnings vs Market: SBLO.F's earnings (15.2% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: SBLO.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: SBLO.F's revenue (11.1% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: SBLO.F's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SBLO.F's Return on Equity is forecast to be high in 3 years time